4//SEC Filing
QUINLAN KEVIN W 4
Accession 0001140361-13-010486
CIK 0000898437other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:20 PM ET
Size
6.4 KB
Accession
0001140361-13-010486
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2013-02-27$6.99/sh+5,000$34,950→ 20,744 total - Exercise/Conversion
Common Stock
2013-02-27$6.99/sh+6,368$44,512→ 27,112 total
Footnotes (1)
- [F1]The stock options were issued under a Performance Grant on June 7, 2011, the date the Compensation Committee of the Company determined that certain performance measures governing the Performance Grant were achieved. The stock options vest in three equal installments as follows: March 1, 2012, January 1, 2013, and January 1, 2014.
Documents
Issuer
ANIKA THERAPEUTICS INC
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001209114
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:20 PM ET
- Size
- 6.4 KB